S2Medical AB (FRA:S21) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 27, 2026)


What is S2Medical AB Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

S2Medical AB's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.


FRA:S21 vs ISRG, BDX, MDLN: Margin of Safety % (DCF Earnings Based) Comparison

For the Medical Instruments & Supplies subindustry, S2Medical AB's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


S2Medical AB Margin of Safety % (DCF Earnings Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, S2Medical AB's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where S2Medical AB's Margin of Safety % (DCF Earnings Based) falls into.



S2Medical AB Business Description

Other Exchanges S2M:Sweden
Address Sunnorpsgatan 5, Linkoping, SWE, 582 73
S2Medical AB is a research-intensive MedTech company from Sweden. The company develops products within the entire wound healing process from debridement and granulation to re-epithelialization. products for the initial phase of a wound's healing process until the end, when the wound is completely healed. S2Medical also has in its portfolio the product NoSmell for odor removal which is procured in several different Swedish healthcare regions.